Free company profile — no paywall, no login

RECCE PHARMACEUTICALS LTD

Perth, Australia

RECCE PHARMACEUTICALS LTD, Perth, Australia · Registration Number: 124 849 065 · LEI: 549300TKQWXKEHP10T28 · Company Type: Ltd. · Status: active. Revenue, earnings and total assets included. · Ownership and management network included. · Free company profile — no paywall, no login

7.508.909 A$

Umsatz2013: 387,00 A$2014: 97.142 A$2015: 113.854 A$2016: 177.020 A$2017: 139.295 A$2018: 1.288.518 A$2019: 679.624 A$2020: 1.121.727 A$2021: 1.637.382 A$2022: 3.084.955 A$2023: 4.365.216 A$2024: 5.028.358 A$2025: 7.508.909 A$
2013201420152016201720182019202020212022202320242025

Corporate purpose

Die Recce Pharmaceuticals Ltd ist ein Biotechnologieunternehmen, das sich auf die Erforschung, Entwicklung und Markteinführung von synthetischen Antiinfektiva in Australien, den USA und Großbritannien konzentriert. Das wichtigste Entwicklungsmedikament des Unternehmens, RECCE 327, soll Blutinfektionen und Sepsis behandeln, die durch E. coli- und S. aureus-Bakterien, einschließlich ihrer antibiotikaresistenten Varianten, verursacht werden. Darüber hinaus entwickelt Recce RECCE 529, ein synthetisches Antiinfektivum gegen Viruserkrankungen, und RECCE 435, ein weiteres synthetisches Polymer-Antiinfektivum. Das 2007 gegründete Unternehmen, das ursprünglich Recce Limited hieß, wurde im November 2017 offiziell in Recce Pharmaceuticals Ltd umbenannt. Sein Hauptsitz befindet sich in Sydney, Australien.

Financials

Indicator30.06.201330.06.201430.06.201530.06.201630.06.201730.06.201830.06.201930.06.202030.06.202130.06.202230.06.202330.06.202430.06.2025
Bilanzsumme79.632 A$148.072 A$4.986.581 A$3.720.659 A$1.464.586 A$1.143.737 A$922.184 A$3.244.107 A$21,7 Mio. A$12,6 Mio. A$2.555.869 A$6.369.614 A$12,4 Mio. A$
Gewinn−292.460 A$−272.416 A$−450.166 A$−4.840.358 A$−3.025.504 A$−1.674.288 A$−2.789.197 A$−4.316.737 A$−13,5 Mio. A$−11 Mio. A$−13,1 Mio. A$−17,7 Mio. A$−21,4 Mio. A$
Umsatz387,00 A$97.142 A$113.854 A$177.020 A$139.295 A$1.288.518 A$679.624 A$1.121.727 A$1.637.382 A$3.084.955 A$4.365.216 A$5.028.358 A$7.508.909 A$
Eigenkapital−75.202 A$−56.189 A$4.714.110 A$3.513.861 A$590.144 A$694.915 A$−405.604 A$2.312.580 A$20,5 Mio. A$10,1 Mio. A$−2.588.804 A$−9.523.768 A$−3.052.004 A$
EK-Quote−94,4 %−37,9 %94,5 %94,4 %40,3 %60,8 %−44 %71,3 %94,6 %79,7 %−101,3 %−149,5 %−24,6 %
Steuern0,00 A$0,00 A$0,00 A$−132.918 A$−139.295 A$−1.288.518 A$−679.624 A$−1.071.727 A$−1.566.031 A$−3.084.955 A$−4.311.202 A$−4.906.010 A$−6.738.274 A$
Kassenbestand42.902 A$94.097 A$4.891.857 A$3.591.382 A$1.090.438 A$679.719 A$403.384 A$2.682.192 A$20,9 Mio. A$11,6 Mio. A$1.561.579 A$4.415.185 A$10,4 Mio. A$
Forderungen179,00 A$5,00 A$15.805,00 A$39.565 A$60.185 A$20.957 A$36.517 A$41.364 A$245.484 A$582.708 A$90.667 A$159.428 A$435.268 A$
Verbindlichkeiten154.566 A$203.808 A$272.471 A$206.798 A$874.442 A$448.822 A$1.327.788 A$931.527 A$1.177.814 A$2.562.164 A$5.144.675 A$15,9 Mio. A$15,5 Mio. A$
Umsatzrendite—−280,4 %−395,4 %−2.734,4 %−2.172 %−129,9 %−410,4 %−384,8 %−825,3 %−356,1 %−299,6 %−351,2 %−285,4 %
Umsatz CAGR——1.615,2 %670,5 %335,6 %90,8 %56,3 %58,7 %85,2 %24,4 %59,2 %45,5 %46,3 %
EK-Rendite——−9,5 %−137,8 %−512,7 %−240,9 %—−186,7 %−65,9 %−109,2 %———

Balance sheet

Position2016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Bilanzsumme3.720.6591.464.5861.143.737922.1843.244.10721.681.55512.623.5222.555.8696.369.61412.414.496
Summe Umlaufvermögen3.637.3791.153.988708.497453.1012.739.40421.180.92312.184.7421.947.4595.136.47211.386.268
Zahlungsmittel und Zahlungsmitteläquivalente3.591.3821.090.438679.719403.3842.682.19220.873.04011.581.9341.561.5794.415.18510.448.808
Kurzfristige Investitionen000000000236.631
Inventar-39.565-60.184-20.957-36.516000000
Nettoforderungen39.56560.18520.95736.51741.364245.484582.70890.667159.428435.268
Sonstige kurzfristige Vermögenswerte6.4323.3657.82113.20015.84862.39920.100295.213561.859502.192
Summe der langfristigen Vermögenswerte83.280310.598435.240469.083504.703500.631438.779608.4091.233.1421.028.228
Langfristige Investitionen0000000000
Sachanlagen Netz82.568310.598435.240468.929504.703500.631438.780608.4101.233.1411.028.228
Immaterielle Vermögenswerte7120015492553320127
Firmenwert0000000000
Übrige langfristige Vermögenswerte-83.280-310.598-435.240-469.083-92-55-34-21-11-7
Summe Verbindlichkeiten und Eigenkapital3.720.6591.464.5861.143.737922.1843.244.10721.681.55512.623.5222.555.8716.369.61412.414.496
Total Verbindlichkeiten206.798874.442448.8221.327.788931.5271.177.8142.562.1645.144.67515.893.38215.466.500
Total kurzfristige Verbindlichkeiten195.060690.295416.3911.273.340885.2261.078.2352.446.8504.849.85215.069.7266.129.279
Rechnungsabgrenzungsposten-6.9780-2.859-737.408000000
Verbindlichkeiten aus Lieferungen und Leistungen18.768255.353125.377124.413159.486487.321481.429948.8873.967.3792.182.712
Kurzfristige Schulden6.97802.859737.40883.235112.58574.762147.878224.0851.750.487
Übrige kurzfristige Verbindlichkeiten169.314434.942288.155411.519642.505478.3291.890.6593.753.08710.878.2622.196.080
Total langfristige Verbindlichkeiten11.737161.28932.43054.44846.30199.578115.314294.823823.6569.337.221
Langfristige Schulden0161.28900014.3640102.688587.1059.017.759
Passive Rechnungsabgrenzungsposten Langfristig0000000000
Latente Steuerschulden nicht kurzfristig0000000000
Übrige langfristige Verbindlichkeiten11.73722.85832.43054.44846.30185.214115.314192.135236.551319.462
Sonstige Verbindlichkeiten022.85800000000
Eigenkapital gesamt3.513.861590.144694.915-405.6042.312.58020.503.74110.061.358-2.588.804-9.523.768-3.052.004
Stammaktie7.418.8638.235.00910.031.50911.573.36918.466.33643.297.30943.968.32144.111.96354.838.71381.501.669
Vorzugsaktien0000000000
Gewinnrücklagen-6.152.533-9.178.037-10.852.325-13.641.522-17.958.259-31.471.625-42.457.902-55.535.324-70.075.871-91.503.960
Kumulierter sonstiger Ergebnisverlust2.247.5311.533.1721.515.7311.662.5491.804.5038.678.0578.550.9398.834.5575.713.3906.950.287
Sonstiges Eigenkapital insgesamt0000000000

Network

VorstandsvorsitzenderVVVorstandsvorsitzenderVVRecce Pharmaceuticals Ltd.Recce Pharmaceuticals Ltd., Sydney, AustralienJames H.-B. G. GaicdJames Hamilton-Bray Graham Gaicd, AustralienJames H.-B. GrahamJames Hamilton-Bray Graham, Australien
Company Person Current relation Former relation CH Foreign register
AbbreviationsVV= CEO / chair of the management board

History

  1. Patent: Verfahren zur Herstellung eines …

    29.01.2021 Patent: Verfahren zur Herstellung eines Biologisch Aktiven Copolymers

  2. Patent: Copolymer und Verfahren zur …

    28.08.2019 Patent: Copolymer und Verfahren zur Behandlung von Bakteriellen …

  3. Patent: Antivirusmittel zur Behandlung …

    17.02.2017 Patent: Antivirusmittel zur Behandlung Viraler Infektionen

  4. Patent: Antimikrobielle Polymere und …

    07.10.2015 Patent: Antimikrobielle Polymere und Ihre Zusammensetzungen

FAQ — RECCE PHARMACEUTICALS LTD

What is the LEI of RECCE PHARMACEUTICALS LTD?
The Legal Entity Identifier (LEI) of RECCE PHARMACEUTICALS LTD is 549300TKQWXKEHP10T28.
What is the registration number of RECCE PHARMACEUTICALS LTD?
RECCE PHARMACEUTICALS LTD is registered under the number 124 849 065 in the official register (Australia).
Where is RECCE PHARMACEUTICALS LTD registered?
RECCE PHARMACEUTICALS LTD has its registered address in Perth, Australia.
Is the register extract of RECCE PHARMACEUTICALS LTD free of charge?
Yes. Eulerpool provides all company register data — including the complete record of RECCE PHARMACEUTICALS LTD — completely free of charge, with no login required.

Official registry record

The complete official register extract — every field from the LEI / company register, free of charge, no login required.

Official registry record — RECCE PHARMACEUTICALS LTD
legal_nameRECCE PHARMACEUTICALS LTD
legal_cityPerth
registration_authority_entity_id124 849 065
legal_jurisdictionAU
lei549300TKQWXKEHP10T28
entity_categoryGENERAL
entity_legal_form_codeR4KK
legal_first_address_lineSuite 10
legal_additional_address_line3 Brodie-hall Drive
legal_postal_code6102
headquarters_first_address_lineLevel 23
headquarters_additional_address_line180 George Street
headquarters_citySydney
headquarters_postal_code2000
next_renewal_date10/15/2024
last_update_date10/6/2023
managing_lou5493001KJTIIGC8Y1R12
registration_statusISSUED
validation_sourcesFULLY_CORROBORATED